This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Jun 23;127(25):3111-2.

doi: 10.1182/blood-2016-04-711762.

To BH3 profile or not to BH3 profile

Matthew D Blunt¹, Andrew J Steele¹

Affiliations

PMID: 27340250
DOI: 10.1182/blood-2016-04-711762

Free article

Comment

To BH3 profile or not to BH3 profile

Matthew D Blunt et al. Blood. 2016.

Free article

. 2016 Jun 23;127(25):3111-2.

doi: 10.1182/blood-2016-04-711762.

Authors

Matthew D Blunt¹, Andrew J Steele¹

Affiliation

¹ UNIVERSITY OF SOUTHAMPTON.

PMID: 27340250
DOI: 10.1182/blood-2016-04-711762

No abstract available

PubMed Disclaimer

Comment on

The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism.
Anderson MA, Deng J, Seymour JF, Tam C, Kim SY, Fein J, Yu L, Brown JR, Westerman D, Si EG, Majewski IJ, Segal D, Heitner Enschede SL, Huang DC, Davids MS, Letai A, Roberts AW. Anderson MA, et al. Blood. 2016 Jun 23;127(25):3215-24. doi: 10.1182/blood-2016-01-688796. Epub 2016 Apr 11. Blood. 2016. PMID: 27069256 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations